The 72nd American Diabetes Association convention heard a new observation of clinical significance in patients who were receiving insulin injections twice daily.
The new observation termed DYMO stands for Dinner Hyperglycaemia and early Morning lOw sugars.
Initially it was an incidental observation made out from Diabetes Tele Management System in use since 1998 at the Jothydev's Diabetes Research Center in Trivandrum, Kerala.
In a subset of subjects with diabetes of more than 15 years duration and age around 60 years on biphasic insulin twice daily, the blood sugars can be very high in the night, but it can come down to dangerously low levels in the early morning hours.
This observation was confirmed with the support of continuous glucose monitoring data.
Most of the subjects with long term uncontrolled diabetes will have a phenomenon called hypoglycaemia unawareness and low sugars due to DYMO can lead on to major casualties.
The research group headed by Dr. Jothydev Kesavadev, included Dr.Arun Shankar, Gopika Krishnan, Dr. PradeepBabu, Sunitha Jothydev, Geethu Sanal and Jayasree Lally.
Three papers were presented from the Jothydev's Diabetes Research Centre at the ADA.
The ADA is the largest and the biggest global diabetes convention, where more than 15000 physicians, diabetes team members and researchers come together to present and discuss newer treatment strategies and inventions in diabetes.